Recombinant Human IFN-beta 1a (Mammalian) Protein

Citations are publications that use Bio-Techne products. Selected citations for Recombinant Human IFN-beta 1a (Mammalian) Protein include:

• Species: Human
  Sample Types: Whole Cells
  Applications: Bioassay

  MA Cron et al. (2020-10-08), Decreased expression of miR-29 family associated with autoimmune myasthenia gravis J Neuroinflammation, 2020-117(1):294.
  PMID:  33032631
• Species: Human
  Sample Types: Whole Cells
  Applications: Bioassay

  Rasouli J et al. (2015-04-27), Expression of GM-CSF in T Cells Is Increased in Multiple Sclerosis and Suppressed by IFN-beta Therapy. J Immunol, 2015-0194(11):5085-93.
  PMID:  25917097
• Species: Primate
  Sample Types: Whole Cells
  Applications: Bioassay

  Li et al. (2014-04-17), A 20-amino-acid deletion in the neuraminidase stalk and a five-amino-acid deletion in the NS1 protein both contribute to the pathogenicity of H5N1 avian influenza viruses in mallard ducks. PLoS ONE, 2014-09(4):e95539.
  PMID:  24743258
• Species: Human
  Sample Types: Whole Cells
  Applications: Bioassay

  Salvi V et al. (2013-04-22), Dual regulation of osteopontin production by TLR stimulation in dendritic cells. J Leukoc Biol, 2013-094(1):147-58.
  PMID:  23610145
• Species: Human
  Sample Types: Recombinant Protein
  Applications: Bioassay

  Wang et al. (2013-03-21), Enterovirus 71 protease 2Apro targets MAVS to inhibit anti-viral type I interferon responses. PLoS Pathog, 2013-09(3):e1003231.
  PMID:  23555247
• Species: Human
  Sample Types: Whole Cells
  Applications: Control

  Popugaeva E et al. (2012-04-24), Dobrava-Belgrade hantavirus from Germany shows receptor usage and innate immunity induction consistent with the pathogenicity of the virus in humans. PLoS ONE, 2012-07(4):e35587.
  PMID:  22545121
• Species: Human
  Sample Types: Whole Cells
  Applications: Bioassay

  Witte K et al. (2009-10-01), Despite IFN-lambda receptor expression, blood immune cells, but not keratinocytes or melanocytes, have an impaired response to type III interferons: implications for therapeutic applications of these cytokines. Genes Immun., 2009-110(8):702-14.
  PMID:  19798076

There are no citations that match your criteria.